BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 10634386)

  • 21. Acromegalic cardiomyopathy. Left ventricular filling and hypertrophy in active and surgically treated disease.
    Rossi E; Zuppi P; Pennestrí F; Biasucci LM; Lombardo A; De Marinis L; Loperfido F
    Chest; 1992 Oct; 102(4):1204-8. PubMed ID: 1395769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the Tei index by tissue Doppler imaging in patients with acromegaly: serum growth hormone level is associated with the Tei index.
    Baykan M; Erem C; Gedikli O; Hacihasanoğlu A; Erdoğan T; Koçak M; Kaplan S; Kiriş A; Celik S
    Echocardiography; 2008 Apr; 25(4):374-80. PubMed ID: 18177382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of disease duration on coronary calcification in patients with acromegaly.
    Herrmann BL; Severing M; Schmermund A; Berg C; Budde T; Erbel R; Mann K
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):417-22. PubMed ID: 19373755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acromegalic cardiomyopathy: evaluation of the left ventricular diastolic function in the subclinical stage.
    Ozbey N; Oncül A; Buğra Z; Vural A; Erzengin F; Orhan Y; Büyüköztürk K; Sencer E; Molvalilar S
    J Endocrinol Invest; 1997 Jun; 20(6):305-11. PubMed ID: 9294775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac hypertrophy and function in asymptomatic acromegaly.
    Morvan D; Komajda M; Grimaldi A; Turpin G; Grosgogeat Y
    Eur Heart J; 1991 Jun; 12(6):666-72. PubMed ID: 1830550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Insulin Resistance and Glycemic Metabolic Abnormalities With LV Structure and Function in Middle Age: The CARDIA Study.
    Kishi S; Gidding SS; Reis JP; Colangelo LA; Venkatesh BA; Armstrong AC; Isogawa A; Lewis CE; Wu C; Jacobs DR; Liu K; Lima JA
    JACC Cardiovasc Imaging; 2017 Feb; 10(2):105-114. PubMed ID: 27544896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of patient's age and disease duration on cardiac performance in acromegaly: a radionuclide angiography study.
    Colao A; Cuocolo A; Marzullo P; Nicolai E; Ferone D; Della Morte AM; Petretta M; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1999 May; 84(5):1518-23. PubMed ID: 10323372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Palmieri V; Okin PM; Bella JN; Wachtell K; Oikarinen L; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy.
    Salerno M; Esposito V; Spinelli L; Di Somma C; Farina V; Muzzica S; de Horatio LT; Lombardi G; Colao A
    Clin Endocrinol (Oxf); 2004 May; 60(5):630-6. PubMed ID: 15104568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between blood pressure and glucose tolerance in acromegaly.
    Jaffrain-Rea ML; Moroni C; Baldelli R; Battista C; Maffei P; Terzolo M; Correra M; Ghiggi MR; Ferretti E; Angeli A; Sicolo N; Trischitta V; Liuzzi A; Cassone R; Tamburrano G
    Clin Endocrinol (Oxf); 2001 Feb; 54(2):189-95. PubMed ID: 11207633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum leptin levels in patients with acromegaly before and after correction of hypersomatotropism by trans-sphenoidal surgery.
    Damjanović SS; Petakov MS; Raicević S; Micić D; Marinković J; Dieguez C; Casanueva FF; Popović V
    J Clin Endocrinol Metab; 2000 Jan; 85(1):147-54. PubMed ID: 10634378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of intrinsic myocardial contractility and cardiac fibrosis degree in acromegalic patients treated with somatostatin analogues: a prospective study.
    Bogazzi F; Di Bello V; Palagi C; Donne MG; Di Cori A; Gavioli S; Talini E; Cosci C; Sardella C; Brogioni S; Mariani M; Martino E
    Clin Endocrinol (Oxf); 2005 May; 62(5):590-6. PubMed ID: 15853830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired cardiac performance is a distinct feature of uncomplicated acromegaly.
    Fazio S; Cittadini A; Cuocolo A; Merola B; Sabatini D; Colao A; Biondi B; Lombardi G; Saccà L
    J Clin Endocrinol Metab; 1994 Aug; 79(2):441-6. PubMed ID: 8045960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood pressure and left ventricular geometric pattern determine diastolic function in hypertensive myocardial hypertrophy.
    Müller-Brunotte R; Kahan T; Malmqvist K; Edner M;
    J Hum Hypertens; 2003 Dec; 17(12):841-9. PubMed ID: 14704728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low Frequency of Cardiomyopathy Using Cardiac Magnetic Resonance Imaging in an Acromegaly Contemporary Cohort.
    dos Santos Silva CM; Gottlieb I; Volschan I; Kasuki L; Warszawski L; Balarini Lima GA; Xavier SS; Pedrosa RC; Neto LV; Gadelha MR
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4447-55. PubMed ID: 26431508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of long-term combined treatment with somatostatin analogues and pegvisomant on cardiac structure and performance in acromegaly.
    Auriemma RS; Grasso LF; Galdiero M; Galderisi M; Pivonello C; Simeoli C; De Martino MC; Ferrigno R; Negri M; de Angelis C; Pivonello R; Colao A
    Endocrine; 2017 Mar; 55(3):872-884. PubMed ID: 27295183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acromegalic cardiomyopathy: an echocardiographic study].
    Bertoni PD; Di Michele R; Canziani R; Morandi G
    G Ital Cardiol; 1983; 13(3):152-62. PubMed ID: 6884653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly.
    De Marinis L; Bianchi A; Mazziotti G; Mettimano M; Milardi D; Fusco A; Cimino V; Maira G; Pontecorvi A; Giustina A
    Pituitary; 2008; 11(1):13-20. PubMed ID: 17987389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypertension in acromegaly and in the normal population: prevalence and determinants.
    Vitale G; Pivonello R; Auriemma RS; Guerra E; Milone F; Savastano S; Lombardi G; Colao A
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):470-6. PubMed ID: 16181242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of growth hormone (GH) and insulin-like growth factor I on prostate diseases: an ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects.
    Colao A; Marzullo P; Spiezia S; Ferone D; Giaccio A; Cerbone G; Pivonello R; Di Somma C; Lombardi G
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1986-91. PubMed ID: 10372698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.